A new device to detect early vision loss in glaucoma patients
Advanced CLAD PERG system with minimal patient preparation for clinical settings (Phase II)
['FUNDING_SBIR_2'] · JORVEC CORPORATION · NIH-10846661
This study is working on a new, easy-to-use device that helps doctors check the health of important eye cells to catch eye problems like glaucoma early, so you can get the help you need before your vision is affected.
Quick facts
| Phase | ['FUNDING_SBIR_2'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | JORVEC CORPORATION (nih funded) |
| Locations | 1 site (MIAMI, UNITED STATES) |
| Trial ID | NIH-10846661 on ClinicalTrials.gov |
What this research studies
This research focuses on developing an advanced Pattern Electroretinogram (PERG) system that requires minimal preparation for patients in clinical settings. The goal is to create a compact, user-friendly device that can accurately monitor the health of retinal ganglion cells, which are crucial for vision. By improving the technology used to elicit visual responses, the research aims to enable earlier detection of degenerative retinal disorders like glaucoma, allowing for timely intervention before significant vision loss occurs.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk for glaucoma or those experiencing early signs of retinal dysfunction.
Not a fit: Patients with advanced glaucoma or those who have already experienced significant vision loss may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier diagnosis and treatment of glaucoma, potentially preserving vision for many patients.
How similar studies have performed: Previous research has shown promise in using advanced PERG techniques for monitoring retinal health, indicating that this approach could be effective.
Where this research is happening
MIAMI, UNITED STATES
- JORVEC CORPORATION — MIAMI, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: TOFT-NIELSEN, JONATHON ANTHONY — JORVEC CORPORATION
- Study coordinator: TOFT-NIELSEN, JONATHON ANTHONY
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.